Latest Biotechnology, Pharmaceutical and Healthcare All
China's Ribo acquires tech to bolster RNAi ambitions
In another sign that Chinese firms are hungry for advanced technology to boost their innovative potential, Suzhou Ribo Life Sciences has licensed Life Technologies' technology for the delivery of nove...
Stockwatch: More than one born every minute
As stock markets continue their retreat after the bull market which started in 2002, investors in biotechnology stocks have more than one reason to assume to a ‘risk-off’ stance.
Accovion GmbH ranked in Survey’s Top 10 CRO List: Voted as “Rising Star”
Pharma IQ created a list of the top CROs in the market Accovion GmbH, a full-service provider of clinical development services to the pharmaceutical, biotechnology and medical...
What should you eat when you have HIV?
A new study suggests 1 in 4 stroke survivors will develop symptoms of post-traumatic stress disorder.
Eczema risk linked to antibiotics
Researchers say giving antibiotics to children could raise their risk of developing eczema.
Too many mentally ill being held by police
Watchdogs say police are putting too many mentall ill into cells.
Hunt slams CQC 'cover-up'
Health and Wellbeing Boards: patchy progress to date
Health and Wellbeing Boards: patchy progress to date
Ex-GSK China researchers hit back
Furthermore, he also condemned attempts to discredit GSK's head of R&D in China, who has been dismissed in connection with the affair and has denied any wrongdoing.
NHS cover-up names could be revealed
CQC is reviewing decision to not name those behind possible cover up after baby deaths at a Cumbria hospital.
Gardasil, Cervarix cut US HPV, despite pathetic shot rates
"The bottom line," said CDC Director Dr Tom Frieden, is the types of HPV targeted by the vaccines decreased by 56% – from 11.5% to 5.1% – results he said were "better than expected."
UPDATE 1-Swiss exports sag in May as watches, chemicals hit
* SNB seen affirming commitment to franc cap (Adds details, analyst comment, shares)
South Africa's Cipla Medpro appoints joint acting CEOs
JOHANNESBURG, June 20 (Reuters) - Cipla Medpro South Africa , the drug firm being taken over by India's Cipla Medpro , said on Thursday it had promoted its two deputy chief executives to serve as join...
GSK links with French venture firm to target rare diseases
LONDON (Reuters) - GlaxoSmithKline is investing 17.5 million euros ($23.5 million) in a new venture fund to invest in drugs for rare diseases, underscoring the growing role of big drugmakers in backin...
Not intended for US media Oslo, Norway, 20 June 2013 - Algeta ASA (OSE: ALGETA), a company focused on the development of novel targeted cancer therapeutics, today celebrates the official opening of...
CLOTS 3 Study Delivers Lifesaving Results Using Covidien’s Blood Clot Prevention Technology
Study Shows Sequential Compression Sleeves Reduce DVT Events in Immobile Stroke Patients Covidien (NYSE: COV), a leading global provider of healthcare products, today...
Partnering for Global Impact® 2013 will kick off in Lugano, Switzerland, July 10–11. The second edition features welcome remarks by Percy Barnevik, Chairman, Hand in Han...
REFILE-TABLE-CanBas -2012/13 parent forecast
(Adds previous forecast) , June 20 () - Jun 20 (Reuters) - CanBas Co Ltd PARENT-ONLY EARNINGS ESTIMATES (in billions of yen unless specified) Full Year to Full Year to Jun 30, 2013 Jun 30, 2013...
Kitasato Daiichi seeks approval for cell culture-based pandemic influenza vaccine in Japan
Kitasato Daiichi Sankyo Vaccine, the domestic subsidiary of Daiichi Sankyo Company, is seeking approval for the cell culture-based pandemic influenza vaccine in Japan.
Actavis, Kissei sue Sandoz and Hetero for Rapaflo patent infringement
Actavis and Kissei Pharmaceutical have filed lawsuits under the provisions of the Hatch-Waxman Act against Sandoz and Hetero USA over Rapaflo US patent infringement.
Hungary, Factors to watch, June 20
BUDAPEST, June 20 (Reuters) - Following is a list of events in Hungary and the region, as well as news stories and press reports which may influence financial markets.
Another month, another gliflozin filing in Japan
Bristol-Myers Squibb is also planning a local regulatory submission for its contender Forxiga (dapagliflozin).
Swiss exports sag in May as watches, chemicals hit
ZURICH, June 20 (Reuters) - Swiss exports fell in May, with a particularly sharp decline in watches, pharmaceuticals and chemicals, the Federal Customs Office said on Thursday.
UPDATE 1-Belgian heart drug firm Cardio3 launches IPO
* Shares on sale at 16.65-19.00 euros (Recasts, adds company valuation, reference to bpost)
ALK on track to file dust mite allergy immunotherapy
ALK on track to file dust mite allergy immunotherapy
Vivus ED drug gets to work in less than 15 mins
Vivus ED drug gets to work in less than 15 mins
Pharma urged to engage more with stakeholders
Pharma urged to engage more with stakeholders
Ambrx, Zhejiang collaborate on breast cancer antibody drug conjugate development
US-based Ambrx and China-based Zhejiang Medicine have collaborated to develop and commercialize ARX788, an antibody drug conjugate (ADC) targeting Her2-positive breast cancer.
TABLE-Swiss trade surplus widens to 2.2 bln Sfr in May
ZURICH, June 20 (Reuters) - Exports from Switzerland fell by a real 5.2 percent in May to 17.434 billion Swiss francs, the Federal Customs Office said on Thursday.
Smarter pharma use "can save US $200B+ a year"
Smarter pharma use "can save US $200B+ a year"
Bristol-Myers, AstraZeneca Onglyza diabetes drug fails to meet superiority objective
Bristol-Myers Squibb Company and AstraZeneca have reported that Onglyza failed to demonstrate superiority in reducing cardiovascular deaths, heart attacks and strokes against placebo in type 2 diabete...
Intercept, Repros, Mast, Clovis raise cash in biotech stock frenzy
Intercept will use the $53.3 million in net proceeds from its offering of 1.73 million shares to complete development and fund commercialization of obeticholic acid (OCA) in the treatment of primary b...
TotalScript™ RNA-Seq kits, supplied by Cambio, create libraries from 5 ng total RNA
Supplied in the UK by Cambio and produced by Epicentre® (an Illumina company), the TotalScript™ RNA-Seq kit is a low-input library preparation kit. This kit enables researchers to qui...
BioTek Instruments Announces Establishment of Japanese Office
BioTek Instruments, Inc., continues their global expansion in the microplate-based technology market with the establishment of BioTek Japan. Managed by Mr. Satoshi Sagara, the new direct sales and ser...
Comprehensive new product guide for step-by-step nucleic acid chemistry
Link Technologies have launched their new, free product guide with practical application notes and protocols Link Technologies Ltd, an ISO 9001:2008 certified specialist oligonucleotide reagent...
Belgian heart drug firm Cardio3 launches IPO
BRUSSELS, June 20 (Reuters) - Belgian heart drug specialist Cardio3 BioSciences launched an initial public offering in Brussels and Paris on Thursday, valuing its shares at between 16.65 euros and 19....
German stocks - Factors to watch on June 20
FRANKFURT, June 20 (Reuters) - The following are some of the factors that may move German stocks on Thursday.
Study Shows Walnuts May Protect Against Heart Disease
DERBY, Conn., June 20, 2013 /PRNewswire/ -- Promising results from a new study published in the Journal of the American College of Nutrition provide convincing evidence that walnuts can help prot...
Positive Vote Required to Enable Merger Closing Regulatory News: EpiCept Corporation (Nasdaq OMX Stockholm and OTCQX: EPCT) today issued notice that stockholde...
LONDON, June 20, 2013 /PRNewswire/ -- Based on its recent research on the extremolytes therapeutics market, Frost & Sullivan presents bitop AG with the 2013 European Frost & Sullivan Award for...
HK cosmetic retailer Sa Sa annual profit up 19.7 pct
HONG KONG, June 20 (Reuters) - Hong Kong-based cosmetic retailer Sa Sa International Holdings Ltd posted a 19.7 percent rise in net profit for the year ended March, buoyed by strong demand from mainla...
Suzhou Ribo Licenses siRNA Delivery System from Life Techologies
Suzhou Ribo Life Sciences and Life Technologies of California have stuck a deal giving Ribo exclusive China rights to develop and manufacture siRNA therapeutics using Life's Invivofectamine® Rx de...
Two-fifths of U.S. adults care for sick, elderly relatives
WASHINGTON (Reuters) - Four in 10 U.S. adults are now caring for a sick or elderly family member as more people develop chronic illnesses and the population ages, a new study has found.
Ask a Negative Question, Get a Negative Answer
... Swedish scientists just completed a meta-study (that is, a study of other studies) to get a handle on consumer attitudes toward GMOs and biotechnology in food worldwide. It shows no significa...
DogVacay Releases Inaugural Survey on State of Pet Travel in the U.S.
Findings Reveal Majority of Pet Owners Don’t Trust Airlines with Pets, Spend Time Worrying Rather Than Relaxing While Traveling and Some Even Smuggle Pets onto Planes and into H...
The Non-GMO Project zero tolerance vision creates branding challenges for Kellog
At Real Pharmacy.com...Kashi sources all of their grains from farms in the US. They do import some fruits from other countries, but the soy is primarily grown in the USA. Corn-based ingredients are al...
STOCKS NEWS SINGAPORE-Index headed for biggest daily drop in a year
Singapore shares were headed for their biggest one-day decline in more than a year, tracking weaker global markets after Federal Reserve chairman Ben Bernanke said the central bank would start to redu...
Self-Care and Caregiving Apps Development
By Rajiv Mehta Have I gotten to the end of the beginning in developing tools that help people take care of themselves? With the recent release of Unfrazzle, an app for caregivers, I believe I have. U...
The PCORI Patient Engagement Awards: A Call for Proposals
By Anne C. Beal, MD, Susan Sheridan & Suzanne Schrandt One of our core beliefs at PCORI is that patients, clinicians, and other front-line caregivers, and others across the healthcare community h...
